title: [Incidence and impact of HIV infection among patients with bacterial pleurisy in Lomé (Togo)].
abstract: A prospective study was made in the Tokoin university hospital in Lomé (Togo) to determine the incidence and the impact of HIV among patients with bacterial pleurisy. Two hundred cases of bacterial pleurisy were consecutively included over 17 months. The HIV diagnostic was performed using ELISA (Vironostika HIV Uni-Form II plus O and HIV1 and 2 Bispot Immunocomb II). The 200 cases of pleurisy included 152 (76%) tuberculous pleural effusion and 48 (24%) pleural empyema. Staphylococcus aureus (32%), Streptococcus pneumoniae (14.9%), and Pseudomonas (14.9%) were the main causes of pleural empyema. The HIV incidence was 61% (122/200). The mortality rate ranged from 26.2% in the HIV positive group to 5.1% in HIV negative group (P = 0.0001). The bacterial aspect of pleural empyema was heterogeneous in both groups but Salmonella Enteritidis and Salmonella Typhimurium were identified only among patients with HIV.
authors.affiliation: Microbiologie, université de Lomé, BP 81056, Lomé, Togo. dagnra.ayaotse@voila.fr
authors.forename: A Y
authors.initials: AY
authors.lastname: Dagnra
authors.forename: A H
authors.initials: AH
authors.lastname: Gbadoé
authors.forename: T K
authors.initials: TK
authors.lastname: Edorh
authors.forename: M
authors.initials: M
authors.lastname: Prince-David
authors.forename: O
authors.initials: O
authors.lastname: Tidjani
authors.forename: D H
authors.initials: DH
authors.lastname: Sadzo
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology; D000328:Adult; D001424:Bacterial Infections / Q000453:epidemiology*; D015897:Comorbidity; D016724:Empyema, Pleural / Q000453:epidemiology / Q000382:microbiology; D005260:Female; D015658:HIV Infections / Q000453:epidemiology*; D006679:HIV Seropositivity; D017052:Hospital Mortality; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010998:Pleurisy / Q000453:epidemiology* / Q000382:microbiology; D015995:Prevalence; D011446:Prospective Studies; D012480:Salmonella Infections / Q000453:epidemiology / Q000382:microbiology; D012477:Salmonella enteritidis / Q000302:isolation & purification; D012486:Salmonella typhimurium / Q000302:isolation & purification; D014037:Togo / Q000453:epidemiology; D016896:Treatment Outcome; D014396:Tuberculosis, Pleural / Q000453:epidemiology